Literature DB >> 2989331

Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications.

H M Schulte, G P Chrousos, P W Gold, J D Booth, E H Oldfield, G B Cutler, D L Loriaux.   

Abstract

The continuous 24-h infusion of a maximally stimulating dose (1 micrograms/kg per h) of ovine corticotropin-releasing factor (CRF) in man caused a modest elevation of plasma cortisol (17.2 +/- 1.4 micrograms/dl) and urinary-free cortisol (173 +/- 43 micrograms/24 h) concentrations, which was far less than that seen with a maximally stimulating dose of ACTH (50.4 +/- 2.2 micrograms/dl and 1,200 +/- 94 micrograms/24 h, respectively). The circadian rhythms of plasma ACTH and cortisol were preserved during CRF administration. An intravenous bolus injection of 1 microgram/kg of ovine CRF given to normal volunteers under basal conditions resulted in elevated plasma ACTH and cortisol peak levels (28 +/- 6 pg/ml and 15.0 +/- 1.0 micrograms/dl, respectively). However, no plasma ACTH and cortisol responses were observed when an identical CRF stimulation test was given at the end of the continuous infusion. These findings suggest that the stimulatory activity of exogenous CRF on the ACTH-secreting cells of the pituitary gland is restrained by the negative feedback of cortisol. The persistent circadian rhythm of ACTH, despite a constant level of plasma CRF during the infusion, suggests that the circadian variation in the activity of the hypothalamic-pituitary-adrenal axis cannot be explained solely by circadian periodicity of the endogenous CRF stimulus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989331      PMCID: PMC425532          DOI: 10.1172/JCI111890

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  ACTH LEVELS IN PLASMA IN PREOPERATIVE AND SURGICALLY STRESSED PATIENTS.

Authors:  C E Cooper; D H Nelson
Journal:  J Clin Invest       Date:  1962-08       Impact factor: 14.808

2.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

3.  Presence of corticotropin releasing factor-like immunoreactivity in hypophysial portal blood.

Authors:  D M Gibbs; W Vale
Journal:  Endocrinology       Date:  1982-10       Impact factor: 4.736

4.  Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin.

Authors:  C Rivier; W Vale
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

5.  Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction.

Authors:  G C Curtis; J Mendels
Journal:  Arch Gen Psychiatry       Date:  1976-09

6.  The effects of corticotropin releasing factor on the anterior pituitary function of stalk-sectioned cynomolgus macaques: dose response of cortisol secretion.

Authors:  H M Schulte; G P Chrousos; E H Oldfield; P W Gold; G B Cutler; D L Loriaux
Journal:  J Clin Endocrinol Metab       Date:  1982-10       Impact factor: 5.958

7.  Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion.

Authors:  T H Schürmeyer; P C Avgerinos; P W Gold; W T Gallucci; T P Tomai; G B Cutler; D L Loriaux; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1984-12       Impact factor: 5.958

8.  Influence of the frequency of ovine corticotropin-releasing factor administration on adrenocorticotropin and corticosterone secretion in the rat.

Authors:  C Rivier; W Vale
Journal:  Endocrinology       Date:  1983-10       Impact factor: 4.736

9.  Plasma distribution, disappearance half-time, metabolic clearance rate, and degradation of synthetic ovine corticotropin-releasing factor in man.

Authors:  W E Nicholson; G S DeCherney; R V Jackson; C R DeBold; H Uderman; A N Alexander; J Rivier; W Vale; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1983-12       Impact factor: 5.958

10.  The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.

Authors:  G P Chrousos; H M Schulte; E H Oldfield; P W Gold; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1984-03-08       Impact factor: 91.245

View more
  12 in total

Review 1.  Safety and side effects of human and ovine corticotropin-releasing hormone administration in man.

Authors:  M Nink; U Krause; H Lehnert; J Beyer
Journal:  Klin Wochenschr       Date:  1991-03-18

Review 2.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

3.  Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice.

Authors:  L J Muglia; L Jacobson; S C Weninger; C E Luedke; D S Bae; K H Jeong; J A Majzoub
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

4.  Regulation of Pulsatile and Entropic ACTH Secretion Under Fixed Exogenous Secretagogue Clamps.

Authors:  Ferdinand Roelfsema; Paul Aoun; Paul Y Takahashi; Dana Erickson; Rebecca Yang; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

5.  Corticotropin-releasing factor secretion from dendritic cells stimulated by commensal bacteria.

Authors:  Mariko Hojo; Toshifumi Ohkusa; Harumi Tomeoku; Shigeo Koido; Daisuke Asaoka; Akihito Nagahara; Sumio Watanabe
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

Review 6.  Concept of the aortic aneurysm repair-related surgical stress: a review of the literature.

Authors:  Demetrios N Moris; Michalis I Kontos; Eleftherios I Mantonakis; Antonios K Athanasiou; Eleftherios D Spartalis; Chris N Bakoyiannis; George P Chrousos; Sotirios E Georgopoulos
Journal:  Int J Clin Exp Med       Date:  2014-09-15

7.  Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans.

Authors:  A Sasaki; O Shinkawa; K Yoshinaga
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

Review 8.  Psychoneuroendocrine research in depression. II. Hormonal responses to releasing hormones as a probe for hypothalamic-pituitary-endorgan dysfunction.

Authors:  K P Lesch; R Rupprecht
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

9.  Corticotropin-releasing factor and adrenal function in major depression.

Authors:  D Nerozzi; G Bersani; E Melia; A Magnani; I Antonozzi; G Frajese
Journal:  J Endocrinol Invest       Date:  1988-11       Impact factor: 4.256

10.  Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH.

Authors:  R A Salata; D B Jarrett; J G Verbalis; A G Robinson
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.